Raymond James & Associates’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,993
| Closed | -$631K | – | 4002 |
|
|
2023
Q4 | $631K | Sell |
1,993
-408
| -17% | -$129K | ﹤0.01% | 2796 |
|
|
2023
Q3 | $406K | Sell |
2,401
-161
| -6% | -$27.2K | ﹤0.01% | 2998 |
|
|
2023
Q2 | $556K | Sell |
2,562
-525
| -17% | -$114K | ﹤0.01% | 2851 |
|
|
2023
Q1 | $561K | Sell |
3,087
-3
| -0.1% | -$545 | ﹤0.01% | 2827 |
|
|
2022
Q4 | $607K | Sell |
3,090
-27
| -0.9% | -$5.31K | ﹤0.01% | 2750 |
|
|
2022
Q3 | $701K | Sell |
3,117
-33
| -1% | -$7.42K | ﹤0.01% | 2606 |
|
|
2022
Q2 | $399K | Sell |
3,150
-2,278
| -42% | -$289K | ﹤0.01% | 3037 |
|
|
2022
Q1 | $688K | Sell |
5,428
-81
| -1% | -$10.3K | ﹤0.01% | 2851 |
|
|
2021
Q4 | $722K | Sell |
5,509
-29
| -0.5% | -$3.8K | ﹤0.01% | 2836 |
|
|
2021
Q3 | $677K | Sell |
5,538
-182
| -3% | -$22.2K | ﹤0.01% | 2840 |
|
|
2021
Q2 | $652K | Sell |
5,720
-18
| -0.3% | -$2.05K | ﹤0.01% | 2884 |
|
|
2021
Q1 | $690K | Sell |
5,738
-7
| -0.1% | -$842 | ﹤0.01% | 2762 |
|
|
2020
Q4 | $584K | Sell |
5,745
-229
| -4% | -$23.3K | ﹤0.01% | 2693 |
|
|
2020
Q3 | $462K | Sell |
5,974
-13
| -0.2% | -$1.01K | ﹤0.01% | 2673 |
|
|
2020
Q2 | $667K | Buy |
5,987
+2,358
| +65% | +$263K | ﹤0.01% | 2405 |
|
|
2020
Q1 | $261K | Sell |
3,629
-3,481
| -49% | -$250K | ﹤0.01% | 2850 |
|
|
2019
Q4 | $536K | Buy |
+7,110
| New | +$536K | ﹤0.01% | 2664 |
|